Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia
An Erratum on
Rapid generation of TCR and CD8αβ transgenic virus specific T cells for immunotherapy of leukemia
by Bajwa G and Arber C (2022) Front. Immunol. 13:830021. doi: 10.3389/fimmu.2022.830021
An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Lausanne”.
The original version of this article has been updated.
Keywords: immunotherapy, virus-specific T cells, cytokine capture, transgenic TCR, transgenic CD8, engineered T cells, interferon-gamma
Citation: Frontiers Production Office (2023) Erratum: Rapid generation of TCR and CD8αβ transgenic virus specific T cells for immunotherapy of leukemia. Front. Immunol. 14:1185223. doi: 10.3389/fimmu.2023.1185223
Received: 13 March 2023; Accepted: 13 March 2023;
Published: 24 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org